Clinical trial

Effects of Palmitoylethanolamide on Inner Retinal Function in Glaucoma Patients by Pattern Electroretinogram

NCT04088084

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-03-09

PhasePHASE2

Study timeline

Study start (actual)2015-03-09Date precision: day

Registry last updated2019-09-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Interventions

palmitoylethanolamide (PEA) 600 mgDIETARY_SUPPLEMENT

Sponsors & collaborators

Fondazione IRCCS Policlinico San Matteo di Pavialead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04088084 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.